RELATIVE ABUNDANCE OF ALZHEIMER A-BETA AMYLOID PEPTIDE VARIANTS IN ALZHEIMER-DISEASE AND NORMAL AGING

被引:382
作者
NASLUND, J
SCHIERHORN, A
HELLMAN, U
LANNFELT, L
ROSES, AD
TJERNBERG, LO
SILBERRING, J
GANDY, SE
WINBLAD, B
GREENGARD, P
NORDSTEDT, C
TERENIUS, L
机构
[1] UNIV HALLE WITTENBERG,INST BIOCHEM,D-06120 HALLE,GERMANY
[2] LUDWIG INST CANC RES,CTR BIOMED,S-75124 UPPSALA,SWEDEN
[3] HUDDINGE HOSP,DEPT GERIATR MED,S-14186 STOCKHOLM,SWEDEN
[4] DUKE UNIV,MED CTR,JOSEPH & KATHLEEN BRYAN ALZHEIMERS DIS RES CTR,DEPT MED NEUROL,DURHAM,NC 27710
[5] DUKE UNIV,MED CTR,JOSEPH & KATHLEEN BRYAN ALZHEIMERS DIS RES CTR,DEPT NEUROBIOL,DURHAM,NC 27710
[6] CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT NEUROL,NEW YORK,NY 10021
[7] ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021
关键词
D O I
10.1073/pnas.91.18.8378
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Alzheimer A beta amyloid peptide (A beta) is the principal proteinaceous component of amyloid associated with Alzheimer disease (AD). We have determined the relative abundance of A beta structural variants present in amyloid from brains of 10 individuals with sporadic AD, 2 individuals with familial AD carrying specific mutations in the Alzheimer amyloid precursor protein gene, and 5 nondemented elderly controls. A procedure of isolation based on the extreme insolubility of A beta amyloid was used. The purified, nondigested A beta was analyzed by N-terminal sequencing and electrosprayionization mass spectrometry. Three principal A beta variants were detected-A beta-(1-40), A beta-(1-42), and A beta-(11-42)-in all brains analyzed. The predominant variant in sporadic AD was A beta-(1-40), whereas the principal A beta variant in nondemented elderly controls was A beta-(1-42). The ratio A beta-(1-40)/A beta-(1-42) differed by 10-fold between brains from nondemented controls and those with sporadic AD.
引用
收藏
页码:8378 / 8382
页数:5
相关论文
共 28 条
  • [11] THE CARBOXY TERMINUS OF THE BETA-AMYLOID PROTEIN IS CRITICAL FOR THE SEEDING OF AMYLOID FORMATION - IMPLICATIONS FOR THE PATHOGENESIS OF ALZHEIMERS-DISEASE
    JARRETT, JT
    BERGER, EP
    LANSBURY, PT
    [J]. BIOCHEMISTRY, 1993, 32 (18) : 4693 - 4697
  • [12] THE PRECURSOR OF ALZHEIMERS-DISEASE AMYLOID-A4 PROTEIN RESEMBLES A CELL-SURFACE RECEPTOR
    KANG, J
    LEMAIRE, HG
    UNTERBECK, A
    SALBAUM, JM
    MASTERS, CL
    GRZESCHIK, KH
    MULTHAUP, G
    BEYREUTHER, K
    MULLERHILL, B
    [J]. NATURE, 1987, 325 (6106) : 733 - 736
  • [13] KHACHATURIAN Z, 1984, ARCH NEUROL-CHICAGO, V42, P1097
  • [14] Kim K. S., 1988, NEUROSCI RES COMMUN, V2, P121
  • [15] CHARACTERIZATION OF AMYLOID FAMILIAL BETA-PEPTIDE IN FAMILIAL ALZHEIMERS-DISEASE WITH APP717 MUTATIONS
    LIEPNIEKS, JJ
    GHETTI, B
    FARLOW, M
    ROSES, AD
    BENSON, MD
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 197 (02) : 386 - 392
  • [16] AMYLOID PLAQUE CORE PROTEIN IN ALZHEIMER-DISEASE AND DOWN SYNDROME
    MASTERS, CL
    SIMMS, G
    WEINMAN, NA
    MULTHAUP, G
    MCDONALD, BL
    BEYREUTHER, K
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (12) : 4245 - 4249
  • [17] PEPTIDE COMPOSITIONS OF THE CEREBROVASCULAR AND SENILE PLAQUE CORE AMYLOID DEPOSITS OF ALZHEIMERS-DISEASE
    MILLER, DL
    PAPAYANNOPOULOS, IA
    STYLES, J
    BOBIN, SA
    LIN, YY
    BIEMANN, K
    IQBAL, K
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 301 (01) : 41 - 52
  • [18] MORI H, 1992, J BIOL CHEM, V267, P17082
  • [19] A PATHOGENIC MUTATION FOR PROBABLE ALZHEIMERS-DISEASE IN THE APP GENE AT THE N-TERMINUS OF BETA-AMYLOID
    MULLAN, M
    CRAWFORD, F
    AXELMAN, K
    HOULDEN, H
    LILIUS, L
    WINBLAD, B
    LANNFELT, L
    [J]. NATURE GENETICS, 1992, 1 (05) : 345 - 347
  • [20] DIFFERENCES BETWEEN VASCULAR AND PLAQUE CORE AMYLOID IN ALZHEIMERS-DISEASE
    PRELLI, F
    CASTANO, E
    GLENNER, GG
    FRANGIONE, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 1988, 51 (02) : 648 - 651